TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. II (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on June 2, 2025 and terminate on June 1, 2026. Pursuant to the NCIB, the Company proposes to purchase, from time to time, if it ...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on June 2, 2025 and terminate on June 1, 2026. Pursuant to the NCIB, the Company proposes to purchase, from time to time, if it is ...

PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced the appointment of Dr. Karen Chagin, M.D. as Chief Medical Officer (“CMO”), effective June 9, 2025. Dr. Chagin succeeds Dr. Karen Smith, M.D., Ph.D., MBA, LLM, who has been serving as interim CMO and will remain a member of the Company’s Board of Directors (“Board”). Dr. C ...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Canadian Life Companies Split Corp. (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on June 2, 2025 and terminate on June 1, 2026. Pursuant to the NCIB, the Company proposes to purchase, from time to tim ...

Core Viewpoint - Canadian Banc Corp. has announced its intention to initiate a Normal Course Issuer Bid (NCIB) to repurchase its Preferred Shares and Class A Shares, starting June 2, 2025, and ending June 1, 2026 [1]. Group 1: NCIB Details - The company plans to buy up to 3,742,582 Preferred Shares and 3,778,760 Class A Shares, which represents 10% of the public float of 37,425,824 Preferred Shares and 37,787,604 Class A Shares [2]. - As of May 21, 2025, there were 37,448,395 Preferred Shares and 37,821,364 Class A Shares issued and outstanding [2]. - The company will limit its purchases to a maximum of 748,967 Preferred Shares and 756,427 Class A Shares in any 30-day period, equating to 2% of the issued and outstanding shares as of May 21, 2025 [2]. Group 2: Board's Perspective - The Board of Directors, advised by Quadravest Capital Management Inc., believes that the share repurchases are in the best interests of the company and represent a desirable use of its funds [3]. - All repurchased shares will be cancelled following the NCIB [3]. Group 3: Investment Portfolio - The company invests in a portfolio of six publicly traded Canadian banks, which include Bank of Montreal, Canadian Imperial Bank of Commerce, Royal Bank of Canada, The Bank of Nova Scotia, National Bank of Canada, and The Toronto-Dominion Bank [4].

RISHON LE ZION, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC) reported its financial results for the first quarter of the year 2025. First Quarter 2025 Financial Highlights: Revenues increased by 33.1% to $15.0 million from $11.3 million in the first quarter of the year 2024;Gross profit margin improved to 23.9% compared to 22.7% in the first quarter of the year 2024;EBITDA increased by 86.2% to $1.9 million compared to $1.0 million in the ...

Bombardier’s record-setting Global 7500 aircraft and best-selling Challenger 3500 aircraft will be on display at the Catarina Aviation Show in São Paulo, Brazil, highlighting their exceptional performance qualities, cutting-edge technology and innovative cabin designsIndustry-defining Global 7500 and Challenger 3500 business jets are ideally suited for the Brazilian market, providing exceptional runway performance and range with the smoothest rideWith more than 200 aircraft in service achieving more than 25 ...

SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Apogee Therapeutics is a clinical-stage biotechnology company advancin ...

Q1 2025 highlighted the growing traction of the company’s data collection solutions with leading AI and eCommerce players worldwide Company strategically accelerated investments in scalable infrastructure and next-gen technologies to meet the rising demand for AI-ready data and to future-proof its position among top-tier global companies First quarter 2025 revenue reached $7.1 million, in line with guidance, net profit was at $0.4 million and adjusted EBITDA exceeded guidance, reaching $1.3 million Cash and ...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”) is pleased to announce the successful closing of a US$5.0 million senior note investment in Congruity 360, a leading provider of unstructured data management and risk mitigation solutions. Congruity 360’s Classify360 platform equips organizations with critical capabilities to understand, manage, and secure petabyte-scale unstructured data across cloud, SaaS, and on-premises environments. Its capabilities ...